Ksa Transdermal Skin Patches Market

Transdermal Skin Patches Market - (Product Type - Drug in Adhesive, Matrix, Reservoir, Vapor; Application - Pain Relief, Nicotine Cessation, Hormone replacement therapy, Motion Sickness, Neurological Disorders, and Cardiovascular Disorders; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Kingdom of Saudi Arabia (KSA) Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL26171
  • Published On : Jun 2017
  • No. of Pages : 81
  • Category : Pharmaceutical

1 Preface 
     1.1 Report Scope and Market Segmentation 
     1.2 Research Highlights

2 Assumptions and Research Methodology 
     2.1 Assumptions
     2.2 Research Methodology

3 Executive Summary
     3.1 KSA Transdermal Skin Patches: Market Snapshot
     3.2 Market Share Analysis by Application, 2016

4 Market Overview
     4.1 Market Overview
     4.2 Key Industry Events
     4.3 KSA Transdermal Skin Patches Market: Market Outlook

5 Market Dynamics
     5.1 Drivers and Restraints Snapshot Analysis
     5.2 Drivers
            5.2.1 Increasing geriatric population
            5.2.2 Ongoing developments in transdermal drug delivery system
            5.2.3 Growing preference for self-administration of drugs
            5.2.4 Improved efficacy as compared to other routes of drug administration
            5.2.5 Increasing inclination toward pain free drug delivery 
     5.3 Restraints
            5.3.1 Growing abuse of transdermal patches
            5.3.2 Side effects associated with use transdermal patches
     5.4 Opportunities
            5.4.1 Increasing opportunities for generic players due to patent expiration
            5.4.2 Growing areas of applications
     5.5 Macro Factors Affecting Transdermal Skin Patches Market in KSA
            5.5.1 Government initiatives for health care reforms
            5.5.2 High prevalence of lifestyle diseases 
            5.5.3 Measures for encouraging investments in pharmaceutical sector
     5.6 Key Trends
     5.7 KSA Transdermal Skin Patches Market Size (US$ Mn) Forecast, 2017–2025
     5.8 Transdermal Skin Patches Market: Porter’s Five Force Analysis
     5.9 Transdermal Skin Patches Market: Supply Chain Analysis
     5.10 Regulatory Scenario in Saudi Arabia
     5.11 Saudi Arabia Healthcare Market Trends Analysis
     5.12 Transdermal skin patch product insights
     5.13 Customer Purchase: Decision Making Process
     5.14 Transdermal Skin Patches Market: Analysis of Challenges for Factory Set Up
     5.15 Raw material selection for transdermal skin patch manufacture
     5.16 Transdermal Skin Patches Market: Factory Set Up Process
     5.17 Transdermal Skin Patches Market: Market Share, by Key Players, 2016

6 KSA Transdermal Skin Patches Market Analysis, by Product Type
     6.1 Introduction
     6.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Product Type
     6.3 KSA Transdermal Skin Patches Market Forecast, by Product Type 
            6.3.1 Drug in Adhesive 
            6.3.2 Matrix
            6.3.3 Reservoir
            6.3.4 Vapor
     6.4 Market Attractiveness Analysis, by Product Type

7 KSA Transdermal Skin Patches Market Analysis, by Application
     7.1 Introduction
     7.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Application
     7.3 KSA Transdermal Skin Patches Market Forecast, by Application 
            7.3.1 Pain Relief
            7.3.2 Nicotine Cessation
            7.3.3 Hormone replacement therapy
            7.3.4 Motion Sickness
            7.3.5 Neurological Disorders
            7.3.6 Cardiovascular Disorders
            7.3.7 Others
     7.4 Market Attractiveness Analysis, by Application

8 KSA Transdermal Skin Patches Market Analysis, by Distribution Channel
     8.1 Introduction
     8.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Distribution Channel
     8.3 KSA Transdermal Skin Patches Market Forecast, by Distribution Channel
            8.3.1 Hospital Pharmacies
            8.3.2 Retail Pharmacies
            8.3.3 Online Pharmacies
     8.4 Market Attractiveness Analysis, by Distribution Channel

9 Company Profiles
     9.1 Teva Pharmaceutical Industries Ltd. 
            9.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.1.2. Business Overview
            9.1.3. Product Portfolio 
            9.1.4. Financial Overview 
            9.1.5. SWOT Analysis 
            9.1.6. Strategic overview
     9.2 Luye Pharma Group Ltd. 
            9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.2.2. Business Overview
            9.2.3. Product Portfolio 
            9.2.4. Financial Overview 
            9.2.5. SWOT Analysis 
            9.2.6. Strategic overview
     9.3 Hisamitsu Pharmaceutical Co., Inc.
            9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.3.2. Business Overview
            9.3.3. Product Portfolio 
            9.3.4. Financial Overview 
            9.3.5. SWOT Analysis 
            9.3.6. Strategic overview
     9.4 Novartis AG
            9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.4.2. Business Overview
            9.4.3. Product Portfolio 
            9.4.4. Financial Overview 
            9.4.5. SWOT Analysis 
            9.4.6. Strategic overview
     9.5 Mylan N.V.
            9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.5.2. Business Overview
            9.5.3. Product Portfolio 
            9.5.4. Financial Overview 
            9.5.5. SWOT Analysis 
            9.5.6. Strategic overview
     9.6 Johnson & Johnson
            9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.6.2. Business Overview
            9.6.3. Product Portfolio 
            9.6.4. Financial Overview 
            9.6.5. SWOT Analysis 
            9.6.6. Strategic overview
     9.7 Mundipharma International Ltd
            9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.7.2. Business Overview
            9.7.3. Product Portfolio 
            9.7.4. Financial Overview 
            9.7.5. SWOT Analysis 
            9.7.6. Strategic overview
     9.8 Purdue Pharma L.P.
            9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            9.8.2. Business Overview
            9.8.3. Product Portfolio 
            9.8.4. Financial Overview 
            9.8.5. SWOT Analysis 
            9.8.6. Strategic overview

List of Tables

Table 01: Transdermal Skin Patches Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Transdermal Skin Patches Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Transdermal Skin Patches Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Figures
 
Figure 01: Saudi Arabia Transdermal Skin Patches Market Size (US$ Mn) Forecast, 2017–2025
Figure 02: Transdermal Skin Patches Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 03: KSA Drug in Adhesive Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 04: KSA Matrix Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 05: KSA Reservoir Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 06: KSA Vapor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 07: Transdermal Skin Patches Market Attractiveness Analysis, by Product Type, 2016
Figure 08: Transdermal Skin Patches Market Value Share Analysis, by Application, 2017 and 2025
Figure 09: KSA Pain Relief Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: KSA Nicotine Cessation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: KSA Hormone replacement therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: KSA Motion Sickness Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: KSA Neurological Disorders Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: KSA Cardiovascular Disorders Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: KSA Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Transdermal Skin Patches Market Attractiveness Analysis, by Application, 2015
Figure 17: Transdermal Skin Patches Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 18: KSA Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025
Figure 19: KSA Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025
Figure 20: KSA Online Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025
Figure 21: Transdermal Skin Patches Market Attractiveness Analysis, by Distribution Channel, 2016